Head of Discovery Biology I (Oncology and CVM) @ (September 2023 - January 2026)
Head of Pharmacology (Oncology, CVM) @ (January 2021 - January 2026)
Principal Research Scientist @ (January 2016 - January 2026)
Senior Research Scientist @ (November 2013 - December 2015)
Research Associate @ (January 2012 - October 2013)
Postdoctoral research fellow @ (January 2009 - December 2011)
Post-doctoral Research Fellow @ (September 2007 - November 2008)
Teaching Assistant @ (January 2007 - August 2007)
Ju-Hee Lee Education
Seoul National University
Pharm. MBA
2018-2018
Seoul National University
Ph.D (Tumor biology, epigenetics)
2003-2007
Ju-Hee Lee Skills
Analysis of DNA damage
Apoptosis
Autophagy
Beacon ADC
Cell Culture
Cell Cycle Analysis
Chromatin Immunoprecipitation
Colony formation assay
Comet Assay
DNA methylation
Data Analytics
Drug Development
ELISA
Epigenetics
FACS analysis
Great troubleshooting skills
Immunofluorescence
Immunoprecipitation
MTT and XTT assay
Metaphase spreading analysis
PCR
Solid Tumor
Target Discovery & Validation
Western Blotting
Xenograft (mice model)
real-time PCR
Biochemistry
Clinical Research
Real Time Pcr
Strategic Planning
Leadership
Target Discovery and Validation
Xenograft Mice Model
Pharmaceutical Sales
Microsoft Word
Healthcare
Xenograft
Ju-Hee Lee Summary
Ju-Hee Lee, based in South Korea, is currently a Chief Executive Officer at Archela, Inc. Ju-Hee Lee brings experience from previous roles at Chong Kun Dang Pharm.. Ju-Hee Lee holds a 2018 - 2018 Pharm. MBA @ Seoul National University. With a robust skill set that includes Analysis of DNA damage, Apoptosis, Autophagy, Beacon ADC , Cell Culture and more. Ju-Hee Lee has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Ju-Hee Lee?
Find contact details for 700 million professionals.